SAFE-SSPE
Clinical Surveillance vs. Anticoagulation For low-risk patiEnts with isolated SubSegmental Pulmonary Embolism: a multicenter randomized placebo-controlled non-inferiority trial
Registration:
Sponsors:
Inselspital, Bern University Hospital, University of Bern
Status:
Recruiting
Design
Multicenter randomized placebo-controlled non-inferiority trial comparing recurrent VTE and bleeding outcomes in low-risk patients with subsegmental pulmonary embolism receiving either anticoagulation treatment (rivaroxaban) or placebo
Participating Sites
Lead Network:
DTN
Countries:
Canada, Switzerland, The Netherlands,Lead Investigators
Drahomir Aujesky, MD, MSc
SAFE-SSPE@insel.chSubscribe